Pain. Acute pain
Conditions
Interventions
Intervention 1: Drugs:
1-Ketamine:
Dose: 0.5mg/kg
Number of using: Once
Factory name: Rotexmedica
Manufacturing Country's Name: Germany
Location prescribed: intra-articular
Administration time: 1
Treatment - Drugs
Drugs:
1-Ketamine:
Dose: 0.5mg/kg
Number of using: Once
Factory name: Rotexmedica
Manufacturing Country's Name: Germany
Location prescribed: intra-articular
Administration time: 10 minutes
Drugs:
1-Ketamine:
Dose: 0.5mg/kg
Number of using: Once
Factory name: Rotexmedica
Manufacturing Country's Name: Germany
Location prescribed: peri-articular
Administration time: 10 minutes
Sponsors
Vice chancellor for research, Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: the patient's satisfaction; age between 20 and 60 years old. Exclusion criteria: the lack of patient's satisfaction to spinal anesthesia; history of hypnotics or narcotics throughout 24 hours before the surgery; history of drug abuse, or alcohol- dependency; contraindication of morphin or Ketamine.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 1, 2, 4, 6, 12 and 24 hour after surgery. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Opioid Consumption. Timepoint: 24 hours after surgery. Method of measurement: Milligrams. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactKamran Mahmodi
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed